Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMVR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,225
Award facts
- Contract value 100% obligated
- $49,224.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency valued at $49,224.90 for Keytruda 100 mg/4 mL vials. The award is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents no specific set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million contract vehicle valid through November 2026 that enables the agency to procure an extensive portfolio of pharmaceutical products supporting military healthcare facilities.
Keytruda is a checkpoint inhibitor immunotherapy used primarily in oncology treatment. Through its IDC with the Defense Logistics Agency, DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationwide. The company's contract portfolio demonstrates consistent success in competing for federal pharmaceutical procurement, leveraging its woman-owned small business status and established presence as a SAM.gov-registered vendor since 2001.
Quick answers
Who was awarded contract SPE2DB25FNMVR?
SPE2DB25FNMVR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FNMVR worth?
The government has obligated $49,225 on SPE2DB25FNMVR.
Is contract SPE2DB25FNMVR an order under another contract?
Yes. SPE2DB25FNMVR is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMVR competed?
The extent of competition for SPE2DB25FNMVR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award